Skip to main content
Anteris Technologies Global Corp. logo

Anteris Technologies Global Corp. — Investor Relations & Filings

Ticker · AVR ISIN · US03675P1021 ASX Manufacturing
Open in API
Filings indexed 1,667 across all filing types
Latest filing 2007-09-02 Regulatory Filings
Country US United States of America
Listing ASX AVR

About Anteris Technologies Global Corp.

https://anteristech.com/

Anteris Technologies is a structural heart company focused on the development and commercialization of medical devices for heart valve disease. Its lead product is the DurAVR® Transcatheter Heart Valve (THV), a biomimetic valve designed for patients with severe aortic stenosis. The DurAVR® THV is engineered to mimic the performance of a healthy human aortic valve, aiming to restore normal, laminar blood flow. Clinical studies have shown the device delivers a favorable hemodynamic profile, characterized by low pressure gradients and a significant reduction in prosthesis-patient mismatch (PPM), even in patients with challenging anatomies. The company is advancing its technology through pivotal clinical trials to establish a new standard in transcatheter aortic valve replacement (TAVR) and improve long-term patient outcomes.

Recent filings

Filing Released Lang Actions
Lapse of Options 1 page ?Kb
Regulatory Filings Classification · 95% confidence The document is a short announcement to the Australian Stock Exchange regarding the lapse of options that were not exercised by their expiry date. It lists the number and type of options that have lapsed and notes the number of options exercised to date. There is no financial data, no detailed report, and no indication of a meeting or voting results. The document is brief (1066 characters) and serves as a regulatory announcement about option expirations. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2007-09-02 English
Preliminary Final Report 41 pages ?Kb
Annual Report Classification · 100% confidence The document is titled 'Appendix 4E - Preliminary Final Report for the year ended 30 June 2007' and includes detailed financial results, directors' report, operating results, and remuneration report for the full fiscal year ended 30 June 2007. It contains comprehensive financial data, operational commentary, and governance information typical of an annual report. The presence of audited financial statements and detailed director information further supports this classification. The document is lengthy (15,000 characters) and contains the full report, not just an announcement or summary. Therefore, it fits the definition of an Annual Report (10-K equivalent). FY 2007
2007-08-27 English
Non-Renounceable Issue Prospectus 31 pages ?Kb
Capital/Financing Update Classification · 100% confidence The document is titled 'Prospectus' and details an offer of new shares and attaching new options by bioMD Limited. It includes information about the offer price, number of shares and options offered, rights attaching to the securities, important dates, and regulatory compliance with ASIC and ASX. The document is a formal offer document for raising capital through issuing new shares and options, which is characteristic of a capital raising or financing document. It is not an annual report, earnings release, or any other type of report. It is a detailed prospectus for a share issue, which fits the definition of a Capital/Financing Update (CAP).
2007-08-21 English
Appendix 3B 9 pages ?Kb
Capital/Financing Update Classification · 95% confidence The document is an announcement to the Australian Stock Exchange regarding an Appendix 3B filing, which is a standard form used in Australia for announcing new issues of securities and applying for quotation of additional securities. The content includes detailed information about a non-renounceable issue of new shares and options, a timetable for the rights issue, terms of the securities, and a quotation agreement. There are no financial statements, management discussion, or detailed financial results presented. The document is a regulatory announcement about capital raising and securities issuance, not a full financial report or earnings release. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (over 13,000 characters), indicating it is not a brief notice but a full announcement of a capital raising event.
2007-08-20 English
Change of Director`s Interest Notice 2 pages ?Kb
Director's Dealing Classification · 100% confidence The document is an announcement to the Australian Stock Exchange regarding a change in a director's interest in securities, specifically an Appendix 3Y form which is a Change of Director's Interest Notice. It details the director's shareholdings before and after the transaction, the nature of the transaction (on-market purchase), and references relevant listing rules and Corporations Act sections. This matches the definition of Director's Dealing filings, which report personal share transactions by company directors and executives (insider trades). The document is short and focused solely on this insider transaction, with no financial statements or other report content.
2007-08-09 English
Change in substantial holding 3 pages ?Kb
Major Shareholding Notification Classification · 100% confidence The document is titled 'Change of Substantial Holder Notice' and includes a Form 604 under the Corporations Act 2001 Section 671B, which is a formal notice of change in interests of a substantial shareholder. It details changes in voting power and share purchases by Mandolin Pty Ltd, a substantial holder in bioMD Limited. This type of filing is a notification of changes in significant share ownership levels, which matches the definition of 'Major Shareholding Notification' (Code: MRQ). The document is not an announcement of a report, nor does it contain financial statements or management commentary. Therefore, the correct classification is MRQ with high confidence.
2007-08-09 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.